Varenicline as a Repurposable Drug Candidate for ADRD Prevention.

Ma P, Zhou J, Cheng Y, McGeary JE, Taveira TH, Ahmed A, Wu WC, Zamrini E, Dugger BN, Sevilla LNC, Nations JA, Shao Y, Yin Y, Tsuang DW, Logue MW, Ayandeh S, Faselis C, Nelson SJ, Zeng-Treitler Q

Open source

DOI: 10.64898/2026.09.17.26363232
Published: 2026 Sep 20
Container: medRxiv : the preprint server for health sciences
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.09.17.26363232,
  title = {Varenicline as a Repurposable Drug Candidate for ADRD Prevention.},
  author = {Ma P and Zhou J and Cheng Y and McGeary JE and Taveira TH and Ahmed A and Wu WC and Zamrini E and Dugger BN and Sevilla LNC and Nations JA and Shao Y and Yin Y and Tsuang DW and Logue MW and Ayandeh S and Faselis C and Nelson SJ and Zeng-Treitler Q},
  year = {2026},
  journal = {medRxiv : the preprint server for health sciences},
  doi = {10.64898/2026.09.17.26363232},
  url = {https://doi.org/10.64898/2026.09.17.26363232}
}

RIS

TY  - JOUR
TI  - Varenicline as a Repurposable Drug Candidate for ADRD Prevention.
AU  - Ma P
AU  - Zhou J
AU  - Cheng Y
AU  - McGeary JE
AU  - Taveira TH
AU  - Ahmed A
AU  - Wu WC
AU  - Zamrini E
AU  - Dugger BN
AU  - Sevilla LNC
AU  - Nations JA
AU  - Shao Y
AU  - Yin Y
AU  - Tsuang DW
AU  - Logue MW
AU  - Ayandeh S
AU  - Faselis C
AU  - Nelson SJ
AU  - Zeng-Treitler Q
PY  - 2026
JO  - medRxiv : the preprint server for health sciences
DO  - 10.64898/2026.09.17.26363232
UR  - https://doi.org/10.64898/2026.09.17.26363232
ER  -

APA

P, M., J, Z., Y, C., JE, M., TH, T., A, A., WC, W., E, Z., BN, D., LNC, S., JA, N., Y, S., Y, Y., DW, T., MW, L., S, A., C, F., SJ, N., & Q, Z. (2026). Varenicline as a Repurposable Drug Candidate for ADRD Prevention.. medRxiv : the preprint server for health sciences. https://doi.org/10.64898/2026.09.17.26363232

Source records

pubmed · retrieved 2026-09-25T12:27:21.913Z